We appreciate the editorial published in Inside Patient Care: Pharmacy & Clinics pertaining to the role of retail pharmacy in controlled substance take-back programs. However, we believe that the assertion that retail pharmacies will have to register as reverse distributors in order to accept controlled substances is incorrect.
I thank Mr McAbee for his comments regarding my editorial on the role of pharmacy in controlled substance take-back programs, including the proper Drug Enforcement Administration (DEA) registration process for pharmacies to accept controlled substances with the intent of destruction.
The new year brings new opportunities for self-improvement and growth, and Inside Patient Care: Pharmacy & Clinics will continue to provide resources for the entire healthcare team as it relates to improving patient care and your business model.
"As we start the new calendar year, many patients have new insurance coverage, changes to their existing insurance coverage, or an annual deductible that is reset in January.”
Medically complex children with special healthcare needs (CSHCN) are often described as having at least 1 chronic condition resulting in high family-identified service needs, functional limitations, which usually require medical equipment, functional disabilities, the involvement of multiple subspecialists, and increased use of healthcare services.
Stakeholder Perspective by Amanda Persaud, MD, Tammy Tempfer, CPNP, MSN, and Jeffrey Yu, MD, PhD.
Sivextro (Tedizolid Phosphate) Approved by the FDA for the Treatment of Adults with Acute Bacterial Skin and Skin-Structure Infections
An acute bacterial skin and skin-structure infection (ABSSSI) is a bacterial infection of the skin with a lesion size of e75 cm2, which is measured by the area of redness, edema, or induration. The types of infections that comprise ABSSSIs include cellulitis or erysipelas, major cutaneous abscesses, and wound infections; these infections can be life-threatening and may require hospitalization and surgery.
In clinical practice, sleep concerns associated with the use of stimulant medications for attention-deficit/ hyperactivity disorder (ADHD) are common. Parents have numerous concerns regarding the quantity and quality of their child’s sleep, as well as the known side effects of ADHD medications that interfere with sleep initiation and maintenance. It is key for community pharmacists and retail clinicians to understand these concerns and be able to address questions about possible solutions.
To clinicians, few sights are more frightening than an infant gasping for air, with oxygen levels falling, struggling with paroxysms of constant coughing. This is the consequence of pertussis transmission, which, in 2013, affected more than 22,000 children and 6000 adults in the United States.
As much as 17% of all children and adolescents in the United States are affected by childhood obesity. Health risks associated with the condition include high blood pressure, impaired glucose tolerance, breathing issues, joint problems, as well as a greater risk for social and psychological problems. The following tips are general guidelines to improve patients’ health and prevent childhood obesity.
Systemic lupus erythematosus (SLE), often seen in women of childbearing age, is an autoimmune disease that affects multiple organ systems. To ensure optimal maternal and fetal health outcomes, proper disease management is key when caring for this high-risk population. Ideally, providers and patients should work together to plan a pregnancy when the disease is in remission. Adequate disease control is crucial as the risk for a flare seems to relate to the level of maternal disease activity in the 6 to 12 months before conception.